The DOI matches its Crossref record; 507 of the 507 references it cites were found in a registry or an index.
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Open accessAbstract
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in maintaining multiorgan health and homeostasis. Endothelial functions in health include dynamic maintenance of vascular tone, angiogenesis, hemostasis, and the provision of an antioxidant, anti-inflammatory, and antithrombotic interface. Dysfunction of the vascular endothelium presents with impaired endothelium-dependent vasodilation, heightened oxidative stress, chronic inflammation, leukocyte adhesion and hyperpermeability, and endothelial cell senescence. Recent studies have implicated altered endothelial cell metabolism and endothelial-to-mesenchymal transition as new features of endothelial dysfunction. Endothelial dysfunction is regarded as a hallmark of many diverse human panvascular diseases, including atherosclerosis, hypertension, and diabetes. Endothelial dysfunction has also been implicated in severe coronavirus disease 2019. Many clinically used pharmacotherapies, ranging from traditional lipid-lowering drugs, antihypertensive drugs, and antidiabetic drugs to proprotein convertase subtilisin/kexin type 9 inhibitors and interleukin 1β monoclonal antibodies, counter endothelial dysfunction as part of their clinical benefits. The regulation of endothelial dysfunction by noncoding RNAs has provided novel insights into these newly described regulators of endothelial dysfunction, thus yielding potential new therapeutic approaches. Altogether, a better understanding of the versatile (dys)functions of endothelial cells will not only deepen our comprehension of human diseases but also accelerate effective therapeutic drug discovery. In this review, we provide a timely overview of the multiple layers of endothelial function, describe the consequences and mechanisms of endothelial dysfunction, and identify pathways to effective targeted therapies. Significance Statement The endothelium was initially considered to be a semipermeable biomechanical barrier and gatekeeper of vascular health. In recent decades, a deepened understanding of the biological functions of the endothelium has led to its recognition as a ubiquitous tissue regulating vascular tone, cell behavior, innate immunity, cell-cell interactions, and cell metabolism in the vessel wall. Endothelial dysfunction is the hallmark of cardiovascular, metabolic, and emerging infectious diseases. Pharmacotherapies targeting endothelial dysfunction have potential for treatment of cardiovascular and many other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–400 of 507
Daiber, A., & Chlopicki, S. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.026 · Cited by 166
Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells
Kraehling, J. R., Chidlow, J. H., Rajagopal, C., Sugiyama, M. G., Fowler, J. W., Lee, M. Y., Zhang, X., Ramírez, C. M., Park, E. J., Tao, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms13516 · Cited by 165
Potential of anti-inflammatory agents for treatment of atherosclerosis
Chistiakov, D. A., Melnichenko, A. A., Grechko, A. V., Myasoedova, V. A., & Orekhov, A. N. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.01.008 · Cited by 165
Metabolic Pathways Fueling the Endothelial Cell Drive
Li, X., Kumar, A., & Carmeliet, P. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114731 · Cited by 164
Sims, J. T., Krishnan, V., Chang, C.-Y., Engle, S. M., Casalini, G., Rodgers, G. H., Bivi, N., Nickoloff, B. J., Konrad, R. J., de Bono, S., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.031 · Cited by 164
Cardiovascular effects of cyclooxygenase‐2 inhibitors: a mechanistic and clinical perspective
Patrono, C. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13048 · Cited by 162
Atherosclerosis Is an Epigenetic Disease
Xu, S., Pelisek, J., & Jin, Z. G. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.04.007 · Cited by 161
Self-citationInflammation and cardiovascular diseases: lessons from seminal clinical trials
Liberale, L., Montecucco, F., Schwarz, L., Lüscher, T. F., & Camici, G. G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa211 · Cited by 160
The Vascular Biology of Atherosclerosis and Imaging Targets
Libby, P., DiCarli, M. F., & Weissleder, R. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069633 · Cited by 159
Dong, B., Li, H., Singh, A. B., Cao, A., & Liu, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597229 · Cited by 159
Self-citationNasiri-Ansari, Ν., Dimitriadis, G. K., Agrogiannis, G., Perrea, D., Kostakis, I. D., Kaltsas, G., Papavassiliou, A. G., Randeva, H. S., & Kassi, E. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0749-1 · Cited by 159
Liu, Z., Ma, X., Ilyas, I., Zheng, X., Luo, S., Little, P. J., Kamato, D., Sahebkar, A., Wu, W., Weng, J., et al. (2021) · Theranostics · doi:10.7150/thno.54498 · Cited by 155
Self-citationTHE PIVOTAL ROLE OF THE ENDOTHELIUM IN HAEMOSTASIS AND THROMBOSIS
Verhamme, P. B., & Hoylaerts, M. (2006) · Acta Clinica Belgica · doi:10.1179/acb.2006.036 · Cited by 155
Liu, F., Zhu, Y., Zhang, J., Li, Y., & Peng, Z. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039519 · Cited by 155
Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction
Biering, S. B., Akey, D. L., Wong, M. P., Brown, W. C., Lo, N. T. N., Puerta-Guardo, H. N., de Sousa, F. T. G., Wang, C., Konwerski, J. R., Espinosa, D. A., et al. (2021) · Science · doi:10.1126/science.abc0476 · Cited by 155
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Katneni, U., Alexaki, A., Hunt, R., Schiller, T., DiCuccio, M. N., Buehler, P. W., Ibla, J. C., & Kimchi‐Sarfaty, C. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1715841 · Cited by 154
Circulating markers of angiogenesis and endotheliopathy in COVID‐19
Pine, A. B., Meizlish, M. L., Goshua, G., Chang, C., Zhang, H., Bishai, J. D., Bahel, P., Patel, A. J., Gbyli, R., Kwan, J. M., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020966547 · Cited by 152
Single Cell RNA Sequencing in Atherosclerosis Research
Williams, J. W., Winkels, H., Durant, C. P., Zaitsev, K., Ghosheh, Y., & Ley, K. F. (2020) · Circulation Research · doi:10.1161/circresaha.119.315940 · Cited by 151
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
van der Feen, D. E., Bossers, G. P. L., Hagdorn, Q. A. J., Moonen, J.-R., Kurakula, K., Szulcek, R., Chappell, J., Vallania, F., Donato, M., Kok, K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw4974 · Cited by 150
Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia
Wang, L., Cao, Y., Gorshkov, B. A., Zhou, Y., Yang, Q., Xu, J., Ma, Q., Zhang, X., Wang, J., Mao, X., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104292 · Cited by 150
S1P Control of Endothelial Integrity
Xiong, Y., & Hla, T. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-05879-5_4 · Cited by 149
Long noncoding RNA SNHG12 integrates a DNA-PK–mediated DNA damage response and vascular senescence
Haemmig, S., Yang, D., Sun, X., Das, D., Ghaffari, S., Molinaro, R., Chen, L., Deng, Y., Freeman, D., Moullan, N., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1868 · Cited by 149
Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
Cameron-Vendrig, A., Adili, R., Siraj, M. A., Xu, X., Wang, Y., Lei, X., Afroze, T., Shikatani, E. A., El-Mounayri, O., Noyan, H., et al. (2016) · Diabetes · doi:10.2337/db15-1141 · Cited by 148
Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target
Mitra, R., O’Neil, G., Harding, I. C., Cheng, M. J., Mensah, S. A., & Ebong, E. E. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0691-9 · Cited by 146
Self-citationEndothelial Dysfunction in Sepsis
Helms, J., Kremer, H., Schini‐Kerth, V. B., & Meziani, F. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111311020005 · Cited by 145
Tarbell, J. M., & Ebong, E. E. (2008) · Science Signaling · doi:10.1126/scisignal.140pt8 · Cited by 145
Self-citationMicroRNA-92a Mediates Endothelial Dysfunction in CKD
Shang, F., Wang, S., Hsu, C., Miao, Y., Martin, M., Yin, Y., Wu, C., Wang, Y.-T., Wu, G., Chien, S., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111215 · Cited by 144
Cosentino, F., Hürlimann, D., Delli Gatti, C., Chenevard, R., Blau, N., Alp, N. J., Channon, K. M., Eto, M., Lerch, P., Enseleit, F., et al. (2008) · Heart · doi:10.1136/hrt.2007.122184 · Cited by 143 · cited 1×
“…trials have been performed with BH4 therapy in patients with pulmonary arterial hypertension (National Institutes of Health clinical trials number NCT00435331), systemic hypertension (National Institutes of Health clinical trial number NCT00325962) and hypercholesterolemia (Cosentino et al., 2008).”
BackgroundMicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells
Li, D., Yang, P., Xiong, Q., Song, X., Yang, X., Liu, L., Yuan, W.-J., & Rui, Y. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833a4922 · Cited by 142
Effects of Systemic Inflammation on Endothelium-Dependent Vasodilation
Huang, A. L., & Vita, J. A. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.10.002 · Cited by 142
Ii, M., & Losordo, D. W. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.06.012 · Cited by 142
Gaspari, T. A., Spizzo, I., Liu, H., Hu, Y., Simpson, R. W., Widdop, R. E., & Dear, A. E. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117733626 · Cited by 142
Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model
Cancel, L. M., Ebong, E. E., Mensah, S. A., Hirschberg, C. I., & Tarbell, J. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.930 · Cited by 139
Self-citationSerenelli, M., Böhm, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa496 · Cited by 138
Khemais‐Benkhiat, S., Belcastro, E., Idris-Khodja, N., Park, S., Amoura, L., Abbas, M., Auger, C., Kessler, L., Mayoux, E., Toti, F., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14233 · Cited by 138
Abdelsalam, S. S., Korashy, H. M., Zeidan, A., & Agouni, A. (2019) · Biomolecules · doi:10.3390/biom9070286 · Cited by 138
Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases
Lin, X., Gong, Z., Xiao, Z., Xiong, J., Fan, B., & Liu, J. (2020) · Korean Journal of Radiology · doi:10.3348/kjr.2020.0078 · Cited by 138
Contribution of oxidative stress to endothelial dysfunction in hypertension
Silva, B. R., Pernomian, L., & Bendhack, L. M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00441 · Cited by 137
Kim, J., Lee, K., Kim, J.-H., Lee, D.-K., Park, M., Choi, S., Park, W., Kim, S., Choi, Y. K., Hwang, J. Y., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.010 · Cited by 134
Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
Negro, R. W. D., Wedzicha, J. A., Iversen, M., Fontana, G. A., Page, C. P., Cicero, A. F. G., Pozzi, E., & Calverley, P. M. A. (2017) · European Respiratory Journal · doi:10.1183/13993003.00711-2017 · Cited by 134
Canakinumab in a subgroup of patients with COVID-19
Ucciferri, C., Auricchio, A., Nicola, M. D., Potere, N., Abbate, A., Cipollone, F., Vecchiet, J., & Falasca, K. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30167-3 · Cited by 133
Xiang, Y., Zhang, Y., Tang, Y., & Li, Q. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477479 · Cited by 132
Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis
Vromman, A., Ruvkun, V., Shvartz, E., Wojtkiewicz, G. R., Masson, G. S., Tesmenitsky, Y., Folco, E. J. E., Gram, H., Nahrendorf, M., Świrski, F. K., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz008 · Cited by 132
Li, P., Yin, Y., Guo, T., Sun, X., Ma, H., Zhu, M., Zhao, F., Xu, P. A., Chen, Y., Wan, G., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.017949 · Cited by 131
Long Noncoding RNA Meg3 Controls Endothelial Cell Aging and Function
Boon, R. A., Hofmann, P., Michalik, K., Lozano‐Vidal, N., Berghäuser, D., Fischer, A., Knau, A., Jaé, N., Schürmann, C., & Dimmeler, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.949 · Cited by 131
Endothelium: Its Development, Morphology, Function, and Pathology
(1955) · JAMA · doi:10.1001/jama.1955.02950250065043 · Cited by 131
Mitochondria-targeted antioxidant therapy with MitoQ ameliorates aortic stiffening in old mice
Gioscia‐Ryan, R. A., Battson, M. L., Cuevas, L. M., Eng, J. S., Murphy, M. P., & Seals, D. R. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00670.2017 · Cited by 131
Ganbaatar, B., Fukuda, D., Shinohara, M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Hirata, K., & Sata, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173040 · Cited by 130
Fung, K. Y., Wang, C., Nyegaard, S., Heit, B., Fairn, G. D., & Lee, W. L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00841 · Cited by 129
Fraser, D. D., Patterson, E. K., Slessarev, M., Gill, S. E., Martin, C. M., Daley, M., Miller, M. R., Patel, M. A., dos Santos, C. C., Bosma, K. J., et al. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000194 · Cited by 129
Endothelial Function and Dysfunction: Impact of Metformin
Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128 · cited 1×
“Metformin has a protective effect on the endothelium because of its hypoglycemic actions, and it also has direct AMPK-dependent and -independent pleiotropic effects, which have very recently been reviewed by us and others in detail (Triggle and Ding, 2017; Nafisa et al., 2018; Triggle et al., 2020).”
BackgroundDysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia
Sobrevía, L., & Mann, G. E. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004038 · Cited by 126
Jiang, Y.-H., Jiang, L., Wang, Y.-C., Ma, D., & Li, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00512 · Cited by 126
Dhar, A., Dhar, I., Desai, K. M., & Wu, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01017.x · Cited by 125
Romero, A., Hipólito‐Luengo, Á. S., Villalobos, L. A., Vallejo, S., Valencia, I., Michalska, P., Pajuelo‐Lozano, N., Sánchez‐Pérez, I., Leon, R. M., Bartha, J. L., et al. (2019) · Aging Cell · doi:10.1111/acel.12913 · Cited by 125
Riggs, D. W., Zafar, N., Krishnasamy, S. S., Yeager, R. A., Rai, S. N., Bhatnagar, A., & O’Toole, T. E. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108890 · Cited by 124
He, M., Chen, Z. B., Martin, M., Zhang, J., Sangwung, P., Woo, B. J., Tremoulet, A. H., Shimizu, C., Jain, M. K., Burns, J. C., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.310233 · Cited by 123
Ancion, A., Tridetti, J., Trung, M. N., Oury, C., & Lancellotti, P. (2019) · Cardiology and Therapy · doi:10.1007/s40119-019-00150-w · Cited by 123
Oxidative Stress, GTPCH1, and Endothelial Nitric Oxide Synthase Uncoupling in Hypertension
Wu, Y., Ding, Y., Ramprasath, T., & Zou, M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8112 · Cited by 122
Alshnbari, A. S., Millar, S., O’Sullivan, S. E., & IDRIS, I. R. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00885-z · Cited by 121
Ligand-specific glucocorticoid receptor activation in human platelets
Moraes, L. A., Paul‐Clark, M. J., Rickman, A., Flower, R. J., Goulding, N. J., & Perretti, M. (2005) · Blood · doi:10.1182/blood-2005-04-1723 · Cited by 117
MicroRNAs in endothelial cell homeostasis and vascular disease
Fernandez-Hernando, C. F., & Suárez, Y. (2018) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000424 · Cited by 117
Endothelial Injury and Repair: A Novel Theory for Atherosclerosis
Mannarino, E., & Pirro, M. (2008) · Angiology · doi:10.1177/0003319708320761 · Cited by 116
von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke
Denorme, F., Vanhoorelbeke, K., & Meyer, S. F. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02884 · Cited by 116
Noncoding RNAs in Vascular Diseases
Jaé, N., & Dimmeler, S. (2020) · Circulation Research · doi:10.1161/circresaha.119.315938 · Cited by 116
Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency
Green, S. J. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.05.006 · Cited by 116
Oxidative Stress Induces Endothelial Cell Senescence via Downregulation of Sirt6
Liu, R.-Z., Liu, H., Ha, Y., Tilton, R., & Zhang, W.-B. (2014) · BioMed Research International · doi:10.1155/2014/902842 · Cited by 114
Storage pool diseases illuminate platelet dense granule biogenesis
Ambrosio, A. L., & Pietro, S. M. D. (2016) · Platelets · doi:10.1080/09537104.2016.1243789 · Cited by 113
Xu, S., Xu, Y., Liu, P., Zhang, S., Liu, H., Slavin, S. A., Kumar, S., Koroleva, M., Luo, J., Wu, X., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz303 · Cited by 113
Self-citationPharmacological and Dietary Antioxidant Therapies for Chronic Obstructive Pulmonary Disease
Biswas, S., Hwang, J. W., Kirkham, P., & Rahman, I. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320120004 · Cited by 112
Rask‐Madsen, C., Ihlemann, N., Krarup, T., Christiansen, E., Køber, L., Kistorp, C. N., & Torp-Pedersen, C. T. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2611 · Cited by 111
Antiangiogenic Activity of 2-Deoxy-D-Glucose
Merchan, J. R., Kovács, K., Railsback, J. W., Kurtoğlu, M., Jing, Y., Piña, Y., Gao, N., Murray, T. G., Lehrman, M. A., & Lampidis, T. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013699 · Cited by 111
Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E. J. M., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4215-5 · Cited by 111
PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke
Sinha, R. K., Wang, Y., Zhao, Z., Xu, X. G., Burnier, L., Gupta, N., Fernández, J. A., Martin, G., Kupriyanov, S., Mosnier, L. O., et al. (2018) · Blood · doi:10.1182/blood-2017-10-810895 · Cited by 111
Elesber, A. A., Solomon, H., Lennon, R. J., Mathew, V., Prasad, A., Pumper, G. M., Nelson, R. E., McConnell, J. P., Lerman, L. O., & Lerman, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi749 · Cited by 109
Gao, L., Chalupský, K., Stefani, E., & Cai, H. “. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.025 · Cited by 108
Tarantini, S., Yabluchanskiy, A., Csípő, T., Fülöp, G. Á., Kiss, T., Balasubramanian, P., DelFavero, J., Ahire, C., Ungvari, A., Nyúl‐Tóth, Á., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00101-2 · Cited by 107
Toral, M., Romero, M., Rodríguez‐Nogales, A., Jiménez, R., Robles‐Vera, I., Algieri, F., Chueca, N., Sánchez, M., de la Visitación, N., Olivares, M. M., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800033 · Cited by 106
Lunder, M., Janić, M., Japelj, M., Juretič, A., Janež, A., & Šabović, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0797-6 · Cited by 105
SENCR stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4
Lyu, Q., Xu, S., Lyu, Y., Choi, M., Christie, C. K., Slivano, O. J., Rahman, A., Jin, Z., Long, X., Xu, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810729116 · Cited by 105
Self-citationRifai, M. A., DeFilippis, A. P., McEvoy, J. W., Hall, M. E., Acien, A. N., Jones, M. R., Keith, R. J., Magid, H. S. A., Rodríguez, C. J., Barr, R. G., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.021 · Cited by 104
Peroxiredoxin-1 regulates lipid peroxidation in corneal endothelial cells
Lovatt, M., Adnan, K., Kocaba, V., Dirisamer, M., Peh, G. S. L., & Mehta, J. S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101417 · Cited by 104
Triggle, C. R., & Ding, H. (2015) · Acta Physiologica · doi:10.1111/apha.12644 · Cited by 103
Local Mitochondrial ATP Production Regulates Endothelial Fatty Acid Uptake and Transport
Ibrahim, A., Yucel, N. D., Kim, B., & Arany, Z. P. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.018 · Cited by 103
Wylie‐Sears, J., Levine, R. A., & Bischoff, J. E. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.014 · Cited by 102
Sharma, A., Rizky, L., Stefanovic, N., Tate, M., Ritchie, R. H., Ward, K. W., & de Haan, J. B. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0513-y · Cited by 100
Karagiannis, A. D., Liu, M., Toth, P. P., Zhao, S., Agrawal, D. K., Libby, P., & Chatzizisis, Y. S. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0718-x · Cited by 99
Mensah, S. A., Cheng, M. J., Homayoni, H., Plouffe, B. D., Coury, A. J., & Ebong, E. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186116 · Cited by 98
Self-citationAnvari, E., Wikström, P., Walum, E., & Welsh, N. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1067697 · Cited by 97
Fonseca, V. A., DeVries, J. H., Henry, R. R., Donsmark, M., Thomsen, H. F., & Plutzky, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.01.009 · Cited by 97
Li, Y., Yang, C., Zhang, L., & Yang, P. C. (2017) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-017-0033-5 · Cited by 97
Sena, C. M., Pereira, A. M., Fernandes, R., Letra, L., & Seiça, R. M. F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13756 · Cited by 97
New classification and criteria for diagnosis of diabetes mellitus
Colman, P. G., Thomas, D. W., Zimmet, P., Welborn, T. A., Garcia‐Webb, P., & Moore, M. P. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb139171.x · Cited by 95
Feng, W. H., Chen, L., Nguyen, P. K. P., Wu, S. M., & Li, G. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00165 · Cited by 95
Hyperelongated biglycan: the surreptitious initiator of atherosclerosis
Little, P. J., Osman, N., & O’Brien, K. D. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830dd7c4 · Cited by 93
Self-citationKo, J., Kang, H., Kim, D.-A., Kim, M., Ryu, E., Lee, S., Ryu, J., Roncal, C., Johnson, R. J., & Kang, D. (2019) · The FASEB Journal · doi:10.1096/fj.201901148r · Cited by 93
State-of-the-Art Review: Endothelial Dysfunction in the Pathogenesis of Atherosclerosis
Poredoš, P. (2001) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960100700404 · Cited by 91
COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction
Bermejo-Martín, J. F., Almansa, R., Torres, A., González‐Rivera, M., & Kelvin, D. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa140 · Cited by 91
Li, X., Fang, P., Sun, Y., Shao, Y., Yang, W. Y., Jiang, X., Wang, H., & Yang, X. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101373 · Cited by 90
Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells
Xu, S., Koroleva, M., Yin, M., & Jin, Z. G. (2016) · Translational research · doi:10.1016/j.trsl.2016.05.003 · Cited by 88
Self-citationLncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway
Li, H., Zhao, Q., Chang, L., Wei, C., Bei, H., Yin, Y., Chen, M., Wang, H., Liang, J., & Wu, Y. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1006-7 · Cited by 88
Self-citationINHIBITION OF PROSTACYCLIN PRODUCTION MEDIATES PERMISSIVE EFFECT OF GLUCOCORTICOIDS ON VASCULAR TONE
Axelrod, L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91330-2 · Cited by 87
Vera, R., Sánchez, M., Galisteo, M., Villar, I. C., Jiménez, R., Zarzuelo, A., Pérez‐Vizcaíno, F., & Duarte, J. (2007) · Clinical Science · doi:10.1042/cs20060185 · Cited by 87
Kim, S., Lee, K., Choi, S., Kim, J., Lee, D.-K., Park, M., Park, W., Kim, T., Hwang, J. Y., Won, M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005197 · Cited by 87
Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1
Shosha, E., Xu, Z., Narayanan, S. P., Lemtalsi, T., Fouda, A. Y., Rojas, M., Ji, X., Fulton, D. J., Caldwell, R. W., & Caldwell, R. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041215 · Cited by 85
Xu, S., Xu, Y., Yin, M., Zhang, S., Liu, P., Koroleva, M., Si, S., Little, P. J., Pelisek, J., & Jin, Z. G. (2018) · Theranostics · doi:10.7150/thno.21966 · Cited by 85
Self-citationXiao, Y., Xia, J., Cheng, J., Huang, H., Zhou, Y., Yang, X., Su, X., Ke, Y., & Ling, W. (2019) · Circulation · doi:10.1161/circulationaha.118.036336 · Cited by 85
Soy Isoflavones Inhibit Endothelial Cell Dysfunction and Prevent Cardiovascular Disease
Yamagata, K. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000708 · Cited by 85
Chen, Z., Yu, J., Fu, M., Dong, R., Yang, Y., Luo, J., Hu, S., Li, W., Xu, X., & Tu, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113951 · Cited by 85
Leisegang, M. S., Bibli, S., Günther, S., Pflüger‐Müller, B., Oo, J. A., Höper, C., Seredinski, S., Yekelchyk, M., Schmitz‐Rixen, T., Schürmann, C., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz393 · Cited by 84
Statins prevent NF-κB transactivation independently of the IKK-pathway in human endothelial cells
Hölschermann, H., Schuster, D., Parviz, B., Haberbosch, W., Tillmanns, H., & Muth, H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.019 · Cited by 83
Zhang, H., Zhao, Z., Pang, X.-F., Yang, J., Yu, H., Zhang, Y., Zhou, H. M., & Zhao, J. (2017) · Inflammation · doi:10.1007/s10753-017-0588-3 · Cited by 82
Cellular Biomechanics in Drug Screening and Evaluation: Mechanopharmacology
Krishnan, R., Park, J., Seow, C. Y., Lee, P. V. S., & Stewart, A. G. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.10.005 · Cited by 81
Self-citationPleiotropic and Adverse Effects of Statins—Do Epigenetics Play a Role?
Bridgeman, S. C., & Mamotte, C. D. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242081 · Cited by 81
Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
Poels, K., Schnitzler, J. G., Waissi, F., Levels, J. H. M., Stroes, E. S. G., Daemen, M. J. A. P., Lutgens, E., Pennekamp, A.-M., de Kleijn, D. P. V., Seijkens, T. T. P., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581641 · Cited by 81
Eskens, B. J. M., Zuurbier, C. J., van Haare, J., Vink, H., & van Teeffelen, J. W. G. E. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-175 · Cited by 80
Harding, I. C., Mitra, R., Mensah, S. A., Herman, I. M., & Ebong, E. E. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1721-2 · Cited by 80
Self-citationLi, J., Liang, X., Wang, Y., Zhao, X., & Li, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6803 · Cited by 78
Li, T., Liu, X., Zhao, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20518 · Cited by 77
Joshi, A., Dimitropoulou, C., Thangjam, G. S., Snead, C. M., Feldman, S., Barabutis, N., Fulton, D. J., Hou, Y., Kumar, S., Patel, V. S., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0496oc · Cited by 76
Cavalcanti, D. M. D. H., Lotufo, C. M. C., Borelli, P., Ferreira, Z. S., Markus, R. P., & Farsky, S. H. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707512 · Cited by 76
Statin Treatment and 3′ Polyadenylation of eNOS mRNA
Kosmidou, I., Moore, J. P., Weber, M., & Searles, C. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.154492 · Cited by 76
Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation
Luo, X., Hu, Y., He, S., Ye, Q., Lv, Z., Liu, J., & Chen, X. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.07.008 · Cited by 76
High glucose-induced circHIPK3 downregulation mediates endothelial cell injury
Cao, Y., Yuan, G., Zhang, Y., & Lü, R. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.041 · Cited by 75
Lee, S.-G., Lee, S.-J., Lee, J.-J., Kim, J.-S., Lee, O.-H., Kim, C.-K., Kim, D., Lee, Y.-H., Oh, J., Park, S., et al. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2019.0296 · Cited by 75
Luo, W., Wang, Y., Yang, H., Dai, C., Hong, H., Li, J., Liu, Z., Guo, Z., Chen, X., He, P., et al. (2018) · Aging · doi:10.18632/aging.101506 · Cited by 74
Self-citationZhang, L., Zeng, M., Fan, J., Tarbell, J. M., CURRY, F. E., & Fu, B. M. (2016) · Microcirculation · doi:10.1111/micc.12278 · Cited by 73
Du, L., Chen, E., Wu, T., Ruan, Y., & Wu, S. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s179894 · Cited by 73
Sun, Z., Han, Y., Song, S., Chen, T., Han, Y., & Liu, Y. (2019) · IUBMB Life · doi:10.1002/iub.2151 · Cited by 73
Lesniewski, L. A., Durrant, J., Connell, M., Folian, B. J., Donato, A. J., & Seals, D. R. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq233 · Cited by 72
Yin, Q., Zhang, R., Li, L., Wang, Y.-T., Liu, J., Zhang, J., Bai, L., Cheng, J., Fu, P., & Liu, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730564 · Cited by 72
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro
Cooper, S., Teoh, H., Campeau, M.-A., Verma, S., & Leask, R. L. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03555-2 · Cited by 72
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
Rahadian, A., Fukuda, D., Salim, H. M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., & Sata, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.52100 · Cited by 71
Hang, L., Peng, Y., Xiang, R., Li, X., & Li, Z. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s231916 · Cited by 71
Self-citationBidault, G., Garcia, M., Capeau, J., Morichon, R., Vigouroux, C., & Béréziat, V. (2020) · Cells · doi:10.3390/cells9051201 · Cited by 71
Cheang, W. S., Wong, W. T., Tian, X. Y., Yang, Q., Lee, H. K., He, G., Yao, X., & Huang, Y. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr233 · Cited by 70
Wheller, S. K., & Perretti, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01015-7 · Cited by 70
Yang, Y., Tian, T., Wang, Y., Li, Z., Xing, K., & Tian, G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172516 · Cited by 70
Self-citationInfluence of beta-blockers on endothelial function: A meta-analysis of randomized controlled trials
Peller, M., Ozierański, K., Balsam, P., Grabowski, M., Filipiak, K. J., & Opolski, G. (2015) · Cardiology Journal · doi:10.5603/cj.a2015.0042 · Cited by 69
Siragusa, M., Justo, A. F. O., Malacarne, P. F., Strano, A., Buch, A., Withers, B., Peters, K. G., & Fleming, I. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa213 · Cited by 69
Cheng, Q., Fan, H., Ngo, D., Beaulieu, É., Leung, P. S. C., Lo, C. Y.-W., Burgess, R., van der Zwan, Y. G., White, S. J., Khachigian, L. M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202662 · Cited by 68
Al‐Sharea, A., Murphy, A. J., Huggins, L. A., Hu, Y., Goldberg, I. J., & Nagareddy, P. R. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.02.028 · Cited by 67
Joris, V., Gomez, E. L., Menchi, L., Lobysheva, I. I., Mauro, V. D., Esfahani, H., Condorelli, G., Balligand, J., Catalucci, D., & Dessy, C. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311145 · Cited by 67
Shear-Sensitive lncRNA AF131217.1 Inhibits Inflammation in HUVECs via Regulation of KLF4
Lü, Q., Meng, Q., Qi, M., Li, F., & Liu, B. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12476 · Cited by 67
Rao, K. N. S., Shen, X., Pardue, S., & Krzywanski, D. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101650 · Cited by 67
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis
Xu, S., Liu, B., Yin, M., Королева, М. В., Mastrangelo, M. A., Ture, S. K., Morrell, C. N., Zhang, D. X., Fisher, E. A. A., & Jin, Z. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9376 · Cited by 66
Self-citationZhang, H., Yang, X., Pang, X.-F., Zhao, Z., Yu, H., & Zhou, H. M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3476-8 · Cited by 66
Song, W., Zhang, C., Gou, L., He, L., Gong, Y.-Y., Qu, D. C., Zhao, L., Jin, N., Chan, T., Wang, L., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312316 · Cited by 66
The Protective Effect of Chlorogenic Acid on Vascular Senescence via the Nrf2/HO-1 Pathway
Hada, Y., Uchida, H. A., Otaka, N., Onishi, Y., Okamoto, S., Nishiwaki, M., Takemoto, R., Takeuchi, H., & Wada, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124527 · Cited by 66
LncRNA NKILA regulates endothelium inflammation by controlling a NF-κB/KLF4 positive feedback loop
Zhu, X., Du, J., Yu, J., Guo, R., Feng, Y., Qiao, L., Xu, Z., Yang, F., Zhong, G., Liu, F., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.11.001 · Cited by 65
Chang, W. C., Zhu, F., Zheng, H., Zhou, Z., Miao, P., Zhao, L., & Mao, Z. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.09.021 · Cited by 65
Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
Brancaleone, V., Mitidieri, E., Flower, R. J., Cirino, G., & Perretti, M. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217034 · Cited by 64
Nox4 regulates the eNOS uncoupling process in aging endothelial cells
Lee, H.-Y., Zeeshan, H. M. A., Kim, H., & Chae, H. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.09.010 · Cited by 64
Cao, L., Zhang, Z., Li, Y., Zhao, P., & Chen, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.042 · Cited by 64
Sasaki, N., Itakura, Y., & Toyoda, M. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00533-w · Cited by 64
Yu, L., Liang, Q., Zhang, W., Liao, M., Wen, M., Zhan, B., Bao, H., & Cheng, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101095 · Cited by 63
Xu, Y., Xu, S., Liu, P., Koroleva, M., Zhang, S., Si, S., & Jin, Z. G. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007134 · Cited by 62
Self-citationThe Glycolytic Enzyme PFKFB3 Controls TNF-α-Induced Endothelial Proinflammatory Responses
Zhang, R., Li, R., Liu, Y., Li, L., & Tang, Y.-Q. (2018) · Inflammation · doi:10.1007/s10753-018-0880-x · Cited by 62
Kajikawa, M., Higashi, Y., Tomiyama, H., Maruhashi, T., Kurisu, S., Kihara, Y., Mutoh, A., & Ueda, S. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.054 · Cited by 62
Yue, W., Li, Y., Ou, D., & Yang, Q. (2019) · IUBMB Life · doi:10.1002/iub.2046 · Cited by 62
Chłopicki, S., & Gryglewski, R. J. (2005) · PubMed · Cited by 61
Wang, X., Chen, X., Zhang, X., Su, C., Yang, M., He, W., Du, Y., Si, S., Wang, L., & Hong, B. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102650 · Cited by 61
Nomoto, H., Miyoshi, H., Furumoto, T., Oba, K., Tsutsui, H., Miyoshi, A., Kondo, T., Tsuchida, K., Atsumi, T., Manda, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135854 · Cited by 60
Endothelial Dysfunction and the Pathogenesis of Atherosclerosis
Gimbrone, M. A. (1980) · Springer eBooks · doi:10.1007/978-1-4612-6071-4_84 · Cited by 60
Choi, S., Kim, J., Kim, J., Lee, D.-K., Park, W., Park, M., Kim, S., Hwang, J. Y., Won, M., Choi, Y. K., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.193 · Cited by 60
Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
Haybar, H., Shokouhian, M., Bagheri, M., Davari, N., & Saki, N. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.010 · Cited by 60
Jeong, J., Lee, J., Lim, J., Cho, S., An, S., Lee, M., Yoon, N., Seo, M., Lim, S., & Park, S. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0312-5 · Cited by 60
The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease
Zhou, Y., Little, P. J., Downey, L., Afroz, R., Wu, Y., Ta, H. T., Xu, S., & Kamato, D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00100 · Cited by 60
Self-citationKLF2 regulates eNOS uncoupling via Nrf2/HO-1 in endothelial cells under hypoxia and reoxygenation
Wu, W., Geng, P., Zhu, J., Li, J., Zhang, L., Chen, W., Zhang, D., Lü, Y., & Xu, X. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.010 · Cited by 59
The protective role of DPP4 inhibitors in atherosclerosis
Liu, H., Guo, L., Xing, J., Li, P., Sang, H., Hu, X., Du, Y., Zhao, L., Song, R., & Gu, H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173037 · Cited by 59
Yang, D., Yang, Z., Chen, L., Kuang, D., Zou, Y., Li, J., Deng, X., Luo, S., Luo, J., He, J., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15278 · Cited by 59
Self-citationHelmke, A., Casper, J., Nordlohne, J., David, S., Haller, H. G., Zeisberg, E. M., & von Vietinghoff, S. (2018) · The FASEB Journal · doi:10.1096/fj.201801238r · Cited by 58
NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli
Linna-Kuosmanen, S., Bosch, V. T., Moreau, P. R., Bouvy‐Liivrand, M., Niskanen, H., Kansanen, E., Kivelä, A. M., Hartikainen, J. E. K., Hippeläinen, M., Kokki, H. J., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa219 · Cited by 58
Cardioprotective properties of bradykinin: role of the B2 receptor
Manolis, A. J., Marketou, M. E., Gavras, I., & Gavras, H. P. (2010) · Hypertension Research · doi:10.1038/hr.2010.82 · Cited by 57
Tang, R., Li, Q., Lv, L., Dai, H., Zheng, M., Ma, K., & Liu, B. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-31 · Cited by 56
LINC00341 exerts an anti-inflammatory effect on endothelial cells by repressing VCAM1
Huang, T.-S., Wang, K.-C., Quon, S., Nguyen, P., Chang, T.-Y., Chen, Z. B., Li, Y.-S. J., Subramaniam, S., Shyy, J., & Chien, S. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00132.2016 · Cited by 55
Li, X.-X., Ling, S., Hu, M., Ma, Y., Li, Y., & Huang, P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.015 · Cited by 55
Hofnagel, O., Luechtenborg, B., Weißen-Plenz, G., & Robenek, H. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.06.003 · Cited by 54
Lee, H., Youn, S., Cho, H., Kwon, Y., Lee, S.-W., Kim, S.-J., Park, Y.-B., Oh, B., & Kim, H.-S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs283 · Cited by 54
Schuliga, M. J., Javeed, A., Harris, T., Xia, Y., Qin, C. X., Wang, Z., Zhang, X., Lee, P. V. S., Camoretti-Mercado, B., & Stewart, A. G. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0151oc · Cited by 54
Self-citationAtheroprone flow enhances the endothelial-to-mesenchymal transition
Lai, B., Li, Z., He, M., Wang, Y., Chen, L., Zhang, J., Yang, Y., & Shyy, J. Y.-J. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00213.2018 · Cited by 53
Self-citationSystemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019
Case, R., RAMANIUK, A., Martin, P., Simpson, P. J., Harden, C., & Ataya, A. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.06.049 · Cited by 53
Antidiabetic Agents and Endothelial Dysfunction – Beyond Glucose Control
Eriksson, L., & Nyström, T. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12402 · Cited by 52
Jiang, J., Gan, Z., Li, Y., Zhao, W., Li, H., Zheng, J., & Ke, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182746 · Cited by 52
Self-citationJiang, T., Jiang, D., Zhang, L., Ding, M., & Zhou, H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.01.006 · Cited by 52
Yan, J., Wang, J., Huang, H., Huang, Y., Mi, T., Zhang, C., & Zhang, L. (2017) · PubMed · Cited by 52
When endothelial cells go rogue
Chen, P., & Simons, M. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505943 · Cited by 51
Yang, Q., Xue, H., Wong, W. T., Tian, X., Huang, Y., Tsui, S. K., Ng, P. K., Wohlfart, P., Li, H., Xia, N., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01308.x · Cited by 50
Self-citationLiberale, L., Montecucco, F., Camici, G. G., Dallegri, F., Vecchié, A., Carbone, F., & Bonaventura, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170303123734 · Cited by 50
MicroRNAs mediate the senescence-associated decline of NRF2 in endothelial cells
Linna-Kuosmanen, S., Sihvola, V., Kansanen, E., Kaikkonen, M. U., & Levonen, A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.06.007 · Cited by 50
Inzucchi, S. E., Khunti, K., FITCHETT, D. H., Wanner, C., Mattheus, M., George, J. T., Ofstad, A. P., & Zinman, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa321 · Cited by 50
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Triggle, C. R., Ding, H., Marei, I., Anderson, T. J., & Hollenberg, M. D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0677 · Cited by 49
Ma, Z., Zhu, L., Liu, Y., Wang, Z., Yang, Y., Chen, L., & Lu, Q. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00473 · Cited by 49
Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation
Ren, L., Han, F., Xuan, L., Lv, Y., Gong, L., Yan, Y., Wan, Z., Guo, L., Liu, H., Xu, B., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.008 · Cited by 48
Xu, J., Wei, G., Wang, J., Zhu, J., Yu, M., Zeng, X., Wang, H., Xie, W., & Kong, H. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0170-0 · Cited by 48
SIRT1 in Endothelial Cells as a Novel Target for the Prevention of Early Vascular Aging
Guo, Y., Xu, A., & Wang, Y. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000344 · Cited by 47
Yan, F., Li, H.-M., Li, S., He, S.-H., Dai, W.-P., Li, Y., Wang, T., Shi, M., Yuan, H., Xu, Z., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.08.016 · Cited by 47
Self-citationSharma, P., Dong, Y. J., Somers, V. K., Peterson, T. E., Zhang, Y., Wang, S., Li, G., & Singh, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32490-3 · Cited by 47
Descamps, B., Saif, J., Benest, A. V., Biglino, G., Bates, D. O., Chamorro-Jorganes, A., & Emanueli, C. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311400 · Cited by 47
TAK1 Prevents Endothelial Apoptosis and Maintains Vascular Integrity
Naito, H., Iba, T., Wakabayashi, T., Tai-Nagara, I., Suehiro, J., Jia, W., Eino, D., Sakimoto, S., Muramatsu, F., Kidoya, H., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.002 · Cited by 47
Cited by
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
Self-citationEndothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
Gallo, G., Volpe, M., & Savoia, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.798958 · Cited by 446
“In particular, the delivery through nanoparticles of many clinically used drugs such as antihypertensive agents, statins, antidiabetic drugs and interleukin 1β monoclonal antibodies may represent a potential target for treatment of endothelial dysfunction thus yielding potential new therapeutic approaches (78).”
BackgroundXu, S.-W., Ilyas, I., & Weng, J.-P. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00998-0 · Cited by 440
Self-citationJiang, H., Zhou, Y., Nabavi, S. M., Sahebkar, A., Little, P. J., Xu, S., Weng, J., & Ge, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.925923 · Cited by 323
Self-citation
Metadata
- Authors
- Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., Harding, I. C., Ebong, E. E., Cameron, S. J., Stewart, A. G., & Weng, J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 73
- Issue
- 3
- Pages
- 924-967
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3165793489
- Cited by
- 1,142
- References
- 507
- FWCI
- 79.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.